These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28148586)

  • 1. Systemic lupus erythematosus.
    Shaikh MF; Jordan N; D'Cruz DP
    Clin Med (Lond); 2017 Feb; 17(1):78-83. PubMed ID: 28148586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
    Zhang H; Chambers W; Sciascia S; Cuadrado MJ
    Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
    van Schaik M; Arends EJ; Soonawala D; van Ommen E; de Leeuw K; Limper M; van Paassen P; Huizinga TWJ; Toes REM; van Kooten C; Rotmans JI; Rabelink TJ; Teng YKO
    Trials; 2022 Nov; 23(1):939. PubMed ID: 36371234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New biologic therapy for systemic lupus erythematosus.
    Ding HJ; Gordon C
    Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
    Teng YKO; Bruce IN; Diamond B; Furie RA; van Vollenhoven RF; Gordon D; Groark J; Henderson RB; Oldham M; Tak PP
    BMJ Open; 2019 Mar; 9(3):e025687. PubMed ID: 30898822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are lupus animal models useful for understanding and developing new therapies for human SLE?
    Moore E; Putterman C
    J Autoimmun; 2020 Aug; 112():102490. PubMed ID: 32535128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Biologic Therapies for Systemic Lupus Erythematosus.
    Borba HH; Funke A; Wiens A; Utiyama SR; Perlin CM; Pontarolo R
    Curr Rheumatol Rep; 2016 Jul; 18(7):44. PubMed ID: 27299782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial.
    Shipa M; Embleton-Thirsk A; Parvaz M; Santos LR; Muller P; Chowdhury K; Isenberg DA; Doré CJ; Gordon C; Ehrenstein MR;
    Ann Intern Med; 2021 Dec; 174(12):1647-1657. PubMed ID: 34698499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
    Thorbinson C; Oni L; Smith E; Midgley A; Beresford MW
    Paediatr Drugs; 2016 Jun; 18(3):181-95. PubMed ID: 26971103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis.
    Shamliyan TA; Dospinescu P
    Clin Ther; 2017 Jul; 39(7):1479-1506.e45. PubMed ID: 28673504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update οn the diagnosis and management of systemic lupus erythematosus.
    Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan.
    Muller P; Chowdhury K; Gordon C; Ehrenstein MR; Doré CJ
    Trials; 2020 Jul; 21(1):652. PubMed ID: 32677992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.
    Athanassiou P; Athanassiou L
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study.
    Rodziewicz M; Dyball S; Lunt M; McDonald S; Sutton E; Parker B; Bruce IN;
    Lancet Rheumatol; 2023 May; 5(5):e284-e292. PubMed ID: 38251591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.
    Jones A; Muller P; Dore CJ; Ikeji F; Caverly E; Chowdhury K; Isenberg DA; Gordon C; Ehrenstein MR
    BMJ Open; 2019 Dec; 9(12):e032569. PubMed ID: 31848169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pragmatic approaches to therapy for systemic lupus erythematosus.
    Xiong W; Lahita RG
    Nat Rev Rheumatol; 2014 Feb; 10(2):97-107. PubMed ID: 24166241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of belimumab in central nervous system demyelinating syndromes with systemic lupus erythematosus: A case series.
    Liu Y; Fan Q; Jia C; Wan Q; Yang H
    Medicine (Baltimore); 2023 Jun; 102(25):e34079. PubMed ID: 37352070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.